TUESDAY, Sept. 5, 2017 (HealthDay News) — Despite ongoing debate over the value of prostate cancer screening, a new review says it can indeed reduce a man’s risk of dying from the disease.

Early tumor detection using the prostate-specific antigen (PSA) blood test lowers a man’s risk of prostate cancer death by 25 percent to 32 percent, the new analysis of two major trials of PSA testing found.

“The amount of early diagnosis was very strongly correlated with the reduced risk of prostate…

Continue reading on Health

Leave a Reply

Your email address will not be published.